Indivior Pharmaceuticals (INDV)

• Market cap: $4.75B
• 1 day: -0.72%
• 5 days: 0.47%
• 1 month: 4.71%
• 3 months: 27.25%
• 6 months: 18.26%
• Year to date: 12.54%
• 1 year: 157.43%
• 5 years: 76.59%
• 10 years: 76.59%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Employees: 838